Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.7 HKD | -1.55% | -0.18% | -15.30% |
Apr. 25 | Simcere Pharmaceutical’ Profit Down 23% in 2023 | MT |
Apr. 10 | Simcere Pharmaceutical's Cancer Drug Gets Fast Track Designation From US FDA | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.30% | 1.9B | |
+22.69% | 43.81B | |
+25.15% | 23.01B | |
+18.00% | 15.27B | |
+8.91% | 13.68B | |
+42.72% | 11.96B | |
-7.51% | 6.98B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.22% | 5.59B |
- Stock Market
- Equities
- 2096 Stock
- News Simcere Pharmaceutical Group Limited
- Simcere Pharmaceutical Group's Cancer Drug NDA Accepted by Chinese Regulator